Reports
Reports
Sale
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Asia Pacific
7 Opportunities and Challenges in the Market
8 Asia Pacific In-Vitro Diagnostics Market Analysis
8.1 Key Industry Highlights
8.2 Asia Pacific In-Vitro Diagnostics Historical Market (2017-2023)
8.3 Asia Pacific In-Vitro Diagnostics Market Forecast (2024-2032)
8.4 Asia Pacific In-Vitro Diagnostics Market by Product and Service
8.4.1 Reagents and Kits
8.4.1.2 Historical Trend (2017-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.2 Instruments
8.4.2.2 Historical Trend (2017-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.4.3 Software and Services
8.4.3.2 Historical Trend (2017-2023)
8.4.3.3 Forecast Trend (2024-2032)
8.5 Asia Pacific In-Vitro Diagnostics Market by Technology
8.5.1 Immunoassay/Immunochemistry
8.5.1.2 Historical Trend (2017-2023)
8.5.1.3 Forecast Trend (2024-2032)
8.5.2 Clinical Chemistry
8.5.2.2 Historical Trend (2017-2023)
8.5.2.3 Forecast Trend (2024-2032)
8.5.3 Molecular Diagnostics
8.5.3.2 Historical Trend (2017-2023)
8.5.3.3 Forecast Trend (2024-2032)
8.5.4 Haematology
8.5.4.2 Historical Trend (2017-2023)
8.5.4.3 Forecast Trend (2024-2032)
8.5.5 Microbiology
8.5.5.2 Historical Trend (2017-2023)
8.5.5.3 Forecast Trend (2024-2032)
8.5.6 Blood Glucose Self-Monitoring
8.5.6.2 Historical Trend (2017-2023)
8.5.6.3 Forecast Trend (2024-2032)
8.5.7 Coagulation and Haemostasis
8.5.7.2 Historical Trend (2017-2023)
8.5.7.3 Forecast Trend (2024-2032)
8.5.8 Urinalysis
8.5.8.2 Historical Trend (2017-2023)
8.5.8.3 Forecast Trend (2024-2032)
8.5.9 Others
8.6 Asia Pacific In-Vitro Diagnostics Market by Application
8.6.1 Infectious Diseases
8.6.1.2 Historical Trend (2017-2023)
8.6.1.3 Forecast Trend (2024-2032)
8.6.2 Diabetes
8.6.2.2 Historical Trend (2017-2023)
8.6.2.3 Forecast Trend (2024-2032)
8.6.3 Cardiology
8.6.3.2 Historical Trend (2017-2023)
8.6.3.3 Forecast Trend (2024-2032)
8.6.4 Oncology
8.6.4.2 Historical Trend (2017-2023)
8.6.4.3 Forecast Trend (2024-2032)
8.6.5 Autoimmune Diseases
8.6.5.2 Historical Trend (2017-2023)
8.6.5.3 Forecast Trend (2024-2032)
8.6.6 Nephrology
8.6.6.2 Historical Trend (2017-2023)
8.6.6.3 Forecast Trend (2024-2032)
8.6.7 Others
8.7 Asia Pacific In-Vitro Diagnostics Market by End Use
8.7.1 Hospitals
8.7.1.2 Historical Trend (2017-2023)
8.7.1.3 Forecast Trend (2024-2032)
8.7.2 Laboratories
8.7.2.2 Historical Trend (2017-2023)
8.7.2.3 Forecast Trend (2024-2032)
8.7.3 Homecare
8.7.3.2 Historical Trend (2017-2023)
8.7.3.3 Forecast Trend (2024-2032)
8.7.4 Others
8.8 Asia Pacific In-Vitro Diagnostics Market by Country
8.8.1 China
8.8.2 Japan
8.8.3 India
8.8.4 ASEAN
8.8.5 Australia
8.8.6 Others
9 Regional Analysis
9.1 China
9.1.1 Historical Trend (2017-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Japan
9.2.1 Historical Trend (2017-2023)
9.2.2 Forecast Trend (2024-2032)
9.3 India
9.3.1 Historical Trend (2017-2023)
9.3.2 Forecast Trend (2024-2032)
9.4 ASEAN
9.4.1 Historical Trend (2017-2023)
9.4.2 Forecast Trend (2024-2032)
9.5 Australia
9.5.1 Historical Trend (2017-2023)
9.5.2 Forecast Trend (2024-2032)
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Sysmex Corporation
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Medical & Biological Laboratories Co., Ltd.
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Voxtur Bio Ltd.
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Immulab
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 FUJIFILM Corporation
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Asia Pacific In-Vitro Diagnostics Market: Key Industry Highlights, 2017 and 2032
2. Asia Pacific In-Vitro Diagnostics Historical Market: Breakup by Product and Services (USD Million), 2017-2023
3. Asia Pacific In-Vitro Diagnostics Market Forecast: Breakup by Product and Services (USD Million), 2024-2032
4. Asia Pacific In-Vitro Diagnostics Historical Market: Breakup by Technology (USD Million), 2017-2023
5. Asia Pacific In-Vitro Diagnostics Market Forecast: Breakup by Technology (USD Million), 2024-2032
6. Asia Pacific In-Vitro Diagnostics Historical Market: Breakup by Application (USD Million), 2017-2023
7. Asia Pacific In-Vitro Diagnostics Market Forecast: Breakup by Application (USD Million), 2024-2032
8. Asia Pacific In-Vitro Diagnostics Historical Market: Breakup by End Use (USD Million), 2017-2023
9. Asia Pacific In-Vitro Diagnostics Market Forecast: Breakup by End Use (USD Million), 2024-2032
10. Asia Pacific In-Vitro Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2023
11. Asia Pacific In-Vitro Diagnostics Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Asia Pacific In-Vitro Diagnostics Market Structure.
The market is projected to grow at a CAGR of 5.2% between 2024 and 2032.
The major drivers of the Asia Pacific in-vitro diagnostics market include the rising levels of income, rising standards of living, development of automated IVD systems for laboratories and hospitals, increasing requirement for genetic testing for personalised health care, and supportive government policies.
Expanding healthcare infrastructure and rising number of IVD (in vitro diagnostics) products being launched by key players are the key industry trends propelling the market's growth.
The major regions in the industry are China, Japan, India, ASEAN, and Australia, among others.
The various products and services in the market are reagents and kits, instruments, software and services.
Based on technology, the market is segmented into immunoassay/immunochemistry, clinical chemistry, molecular diagnostics, haematology, microbiology, blood glucose self-monitoring, coagulation and haemostasis, and urinalysis, among others.
The major applications of the market are infectious diseases, diabetes, cardiology, oncology, autoimmune diseases, and nephrology, among others.
The end-uses of the market are hospitals, laboratories, and homecare, among others.
The major players in the industry are Sysmex Corporation, Medical & Biological Laboratories Co., Ltd., Voxtur Bio Ltd., Immulab, and FUJIFILM Corporation, among others.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.